RAPGEF3 and irritable bowel syndrome: We found that EA at ST36 and ST37 attenuated PI-IBS associated visceral and somatic hypersensitivity, and correlated with the regulatory mechanism of Epac1 and Piezo2 both in the colon and L5–S2 DRGs.